Virios Therapeutics Inc
For the period ended Jun 18, 2024. Filed Apr 25, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 18, 2024 · Filed Apr 25, 2024
Use the contents to explore the available documents and sections.
Contents
PROXY STATEMENT
ANNUAL MEETING OF STOCKHOLDERS
To Be Held June 18, 2024
IMPORTANT NOTICE REGARDING AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL STOCKHOLDER MEETING TO BE HELD ON TUESDAY, JUNE 18, 2024
Copies of this Proxy Statement, form of proxy card, and Annual Report on Form 10-K, as amended (the “Annual Report”), are available at https://ir.virios.com/events-presentations/meeting.
Your vote is important. Please vote in one of these ways:
| 1) | BY INTERNET: Go to http://www.proxyvote.com and follow the instructions. You will need to enter the control number printed on your proxy card; |
| 2) | BY TELEPHONE: Call toll-free 1-800-690-6903 and follow the instructions. You will need to enter the control number printed on your proxy card; |
| 3) | IN WRITING: Complete, sign, date and promptly return your proxy card in the enclosed envelope; or |
| 4) | AT THE ANNUAL MEETING: Follow the instructions that will be available at https://agm.issuerdirect.com/viri during the virtual Annual Meeting. |
This Proxy Statement and the accompanying proxy card and Annual Report are intended to be sent or given to stockholders of Virios Therapeutics, Inc. (the “Company”, “Virios”, “we”, “us” or “our”) on or about April 25, 2024, in connection with the solicitation of proxies on behalf of our Board of Directors (our “Board”) for use at our 2024 Annual Meeting of Stockholders (the “Annual Meeting”), to be held virtually on Tuesday, June 18, 2023, at 11:00 a.m. Eastern Time, and at any adjournment or postponement thereof.
QUESTIONS AND ANSWERS ABOUT THE PROXY MATERIALS AND OUR ANNUAL MEETING
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.